Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001013762-23-001591
Filing Date
2023-10-04
Accepted
2023-10-04 16:10:30
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-10-04

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT fars2023_tffpharma.pdf ARS 775341
  Complete submission text file 0001013762-23-001591.txt   1069125
Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Filer) CIK: 0001733413 (see all company filings)

EIN.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-39102 | Film No.: 231308013
SIC: 2834 Pharmaceutical Preparations